Table V.
Adverse event (CTCAEv3) |
Gr 3 #(%) |
Gr 4 #(%) |
---|---|---|
Skin | 5 (10%) | 0 |
Hepatic transaminases | 5 (10%) | 3 (6%) |
Pulmonary | 18 (36%) | 5 (10%) |
Infection | 12 (24%) | 8 (16%) |
Gastrointestinal | 6 (12%) | 0 |
Hyperbilirubinaemia | 3 (6%) | 1 (2%) |
Renal | 2 (4%) | 0 |
Pain | 1 (2%) | 0 |
Neuropathy | 1 (2%) | 0 |
Tumour lysis | 1 (2%) | 0 |
CTCAEv3, Common Terminology Criteria for Adverse Events v3.0